
Astigmatism Market By Type(Myopic Astigmatism, Hyperopic Astigmatism, Mixed Astigmatism, Others), By Treatments(Corrective Lenses, Orthokeratology {Ortho-K}, Surgeries, Others), By End User(Hospitals, Clinics, Others) , By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast 2024-2033
-
42873
-
Jan 2022
-
176
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
- Astigmatism Market Size, Share, Trends Analysis
- Driving Factors
- Restraining Factors
- Astigmatism Market Segmentation Analysis
- Astigmatism Industry Segments
- Growth Opportunities
- Astigmatism Market Regional Analysis
- Astigmatism Market Key Player Analysis
- Astigmatism Industry Key Players
- Astigmatism Market Recent Development
- Report Scope
The Astigmatism Market was valued at USD 2.69 Billion in 2022. It is expected to reach USD 5.8 Billion by 2032, with a CAGR of 8.12% during the forecast period from 2023 to 2032.
The surge in awareness regarding eye care and advanced treatments are some of the main driving factors for the astigmatism market expansion. Astigmatism is the most common eye issue that makes the vision blurry or partial. It occurs when the cornea or lens has a different or unusual shape than the normal eye structure. Medical researchers specify that astigmatism is 13% of the refractive vision issue that makes it tough to visualize things. This issue is commonly seen in America where approx. 1/3 of American people have astigmatism.
Refractive eye errors are common. According to the National Eye Institute, there are more than 150 million American individuals who have refractive errors, among whom many people do not know about the issue as they can see and visualize things. Moreover, according to WHO, there are almost 1 billion people who have near and distant eye problems that have yet to be resolved. The majority of people have vision impairment issues at the age of 50 years. It is very important to have regular eye check-ups.
Astigmatism can be genetically inherited and is present right from birth. It can be caused after any kind of eye surgery, injuries, cataracts, and keratoconus, a condition where the eye lens gets thin and becomes cone-shaped with time. There are 3 types of astigmatism such as myopic, hyperopic, and mixed.
Many individuals have corneal astigmatism which gives the frontal surface of the eye an oval shape. Depending upon the severity of the eye health, doctors suggest several vision correction methods. Eye surgery can only be done if the condition of the eyes is not good or severe. Astigmatism can be cured by using corrective lenses, LASIK surgery, and orthokeratology.
Doctors prefer the most modern treatment for curing astigmatism i.e. LASIK surgery which is permanent and painless vision correction. Another treatment is refractive eye surgery. The surgery changes the shape of the cornea so that it can visualize things. The demand in the astigmatism market will grow due to the eye disorders and the treatments that will contribute to the market expansion in the coming years.
Driving Factors
Ophthalmic Innovations Propel Astigmatism Market
Rapid technological advancements in ophthalmology are significantly driving the astigmatism market's growth. Innovations in diagnostic instruments and treatment methods, such as improved corneal topography and advanced laser surgery techniques, have enhanced the accuracy and effectiveness of astigmatism diagnosis and treatment.
As these technologies continue to evolve, offering more precise and less invasive treatment options, the market for astigmatism treatment is expected to expand, reflecting the healthcare industry's ongoing commitment to technological innovation and improved patient outcomes.
Corneal Abnormalities Increase Treatment Demand
The increasing occurrence of corneal abnormalities, including astigmatism, is a primary driver for its treatment market. As more individuals are diagnosed with corneal irregularities that impact vision, the demand for effective treatment solutions rises.
The prevalence of conditions leading to astigmatism, such as keratoconus, pterygium, or post-surgical irregularities, contributes to the growing need for specialized ophthalmic care and interventions. This trend is expected to continue as awareness and diagnostic capabilities improve, further boosting the market for astigmatism treatment options.
Global Visual Impairment Prevalence Spurs Market
The widespread prevalence of visual impairments, including astigmatism, across the globe is a significant factor driving the demand for astigmatism treatment. As the global population ages and exposure to risk factors for eye disorders increases, the incidence of vision impairments rises.
This growing prevalence is pushing the healthcare industry to provide more effective and accessible treatment options for astigmatism and other visual conditions. The market is likely to see sustained growth as the need for vision correction and eye health management continues to rise on a global scale.
Restraining Factors
Limited Awareness and Education About Vision Care Restrains the Astigmatism Market Growth
The growth of the astigmatism market is significantly limited by the lack of awareness and education about vision care in certain regions. This lack of knowledge hinders early diagnosis and treatment, as individuals may not recognize the symptoms of astigmatism or understand the importance of regular eye examinations.
Delayed diagnosis can lead to a progression of the condition and more complex treatment requirements. In regions where vision care is not a priority or is inaccessible, the prevalence of untreated astigmatism is higher, limiting the market's potential to reach and treat these populations.
Suitability of Patients for Treatment Options Limits Astigmatism Market Expansion
The expansion of the astigmatism market is also limited by the fact that some patients may not be suitable candidates for certain treatments. Astigmatism varies greatly in its severity and type, and not all treatment options, such as laser eye surgery or certain types of contact lenses, are appropriate for every individual.
Factors like corneal thickness, overall eye health, and the degree of astigmatism can restrict the suitability of these interventions. This limitation means that a segment of the patient population may not benefit from advanced treatments, thereby constraining the market's growth and the universal applicability of certain astigmatism correction methods.
Astigmatism Market Segmentation Analysis
By Type
In the astigmatism market, Myopic Astigmatism is identified as the dominant segment. This form of astigmatism, where the eye is nearsighted in addition to having an irregularly shaped cornea or lens, is widespread due to genetic factors, certain lifestyle habits, and environmental influences. The prevalence of myopic astigmatism has spurred a significant demand for effective corrective measures, ranging from glasses and contact lenses to surgical interventions.
While myopic astigmatism leads in prevalence, Hyperopic Astigmatism, where the eye is farsighted, and Mixed Astigmatism, combining features of both nearsightedness and farsightedness, also represent significant portions of the market. Each type of astigmatism requires a different approach to correction, influencing the variety and specificity of treatments available.
By Treatments
Corrective Lenses are the most widely used treatment for astigmatism, dominating the market segment. This predominance is attributed to their non-invasive nature, ease of use, affordability, and effectiveness in correcting vision for a wide range of astigmatic patients. Corrective lenses, including glasses and contact lenses, are often the first line of treatment prescribed by optometrists and are continually being improved with better materials and designs.
Orthokeratology (Ortho-K) is gaining popularity as a non-surgical option to temporarily correct vision by reshaping the cornea with specialized contact lenses. Surgeries, including LASIK and PRK, offer more permanent solutions and are preferred by those seeking long-term correction. The choice of treatment typically depends on the severity of astigmatism, patient preference, and lifestyle considerations.
By End User
Hospitals emerge as the primary end-users in the astigmatism market. Their dominance is due to the comprehensive care they provide, including advanced diagnostic services, a wide range of treatment options, and the availability of specialized ophthalmic professionals. Hospitals are equipped to offer the latest in surgical treatments for astigmatism, making them a preferred choice for patients seeking permanent corrective solutions.
Clinics also play a significant role, especially for routine check-ups, fitting corrective lenses, and minor procedures. Other end-users include vision care centers and specialty eye care institutions, each contributing to the accessibility and quality of astigmatism treatment.
Astigmatism Industry Segments
By Type
- Myopic Astigmatism
- Hyperopic Astigmatism
- Mixed Astigmatism
- Others
By Treatments
- Corrective Lenses
- Orthokeratology {Ortho-K}
- Surgeries
- Others
By End User
- Hospitals
- Clinics
- Others
Growth Opportunities
Product Development and Approvals in Astigmatism Treatments Fuel Market Growth
The increasing focus on product development and approvals, particularly in innovations related to contact lenses and surgical procedures, creates substantial growth opportunities within the astigmatism market. As technology advances, there's a rising demand for more effective and comfortable treatment options.
Innovations in toric contact lenses, laser eye surgery, and other corrective procedures offer patients improved vision quality and convenience. The ongoing approval of new and advanced products by regulatory bodies enhances market competitiveness and drives growth as companies strive to meet the evolving needs of individuals with astigmatism.
Expansion of Specialized Clinics Offers Growth Opportunity in Astigmatism Market
The expansion of specialized clinics, particularly those focusing on ophthalmic and optometric care, presents a growth opportunity in the astigmatism market. As these clinics become more widespread, they provide accessible and focused care for individuals with astigmatism, offering a range of diagnostic and treatment services.
Specialist care encourages more individuals to seek treatment, increasing market demand for astigmatism correction solutions. Clinics specializing in astigmatism treatments often utilize cutting-edge technologies and treatments, contributing to an expanding market by raising standards of care while broadening access to these specific remedies for astigmatism correction.
Astigmatism Market Regional Analysis
North America Dominates with 43.20% Market Share in the Astigmatism Market
North America holds an astounding 43.20% of the astigmatism market due to its superior healthcare infrastructure and prevalence of vision-related issues. The United States and Canada have a substantial population undergoing routine eye examinations, leading to early diagnosis and treatment of astigmatism. Additionally, the presence of leading ophthalmology clinics and eye care specialists, along with the widespread availability of a range of corrective treatments such as glasses, contact lenses, and refractive surgeries, significantly contributes to this market dominance.
The market dynamics in North America are characterized by continuous technological advancements in vision correction and a high rate of healthcare expenditure. The increasing preference for minimally invasive surgeries and the adoption of innovative products like toric contact lenses and custom LASIK contribute to the market's growth. Moreover, the region's emphasis on eye health awareness and preventive care drives the regular screening and early treatment of astigmatism.
Europe: High Standard of Eye Care and Awareness
Europe's astigmatism market is driven by a high standard of eye care, widespread awareness of vision health, and accessibility to advanced treatments. The region's well-established healthcare systems and focus on regular eye examinations support early detection and treatment of astigmatism. Europe's emphasis on research and development in ophthalmology also contributes to market growth.
Asia-Pacific: Rapid Growth and Increasing Access to Eye Care
The astigmatism market in Asia-Pacific is experiencing exponential growth, driven by more accessible eye care services and rising vision impairment rates. Countries like China, India, and Japan are investing in healthcare infrastructure and eye care awareness campaigns. The region's large and aging population, along with improving economic conditions, presents significant opportunities for market expansion. As access to corrective treatments improves, Asia-Pacific is expected to see substantial growth in the astigmatism market.
Astigmatism Market Key Player Analysis
Astigmatism Market companies play a vital role in eye care and vision correction. Their innovations and treatment solutions provide key advances for this market segment. Novartis AG and Johnson & Johnson Services, Inc. are leaders in the market, offering a range of contact lenses and surgical options for astigmatism correction. Their commitment to research and product development significantly impacts market trends towards more advanced and comfortable vision correction methods.
Bauch and Lomb and CooperVision are key players known for their wide array of contact lenses, including those specifically designed for astigmatism. Their strategic positioning emphasizes product variety and technological advancement in lens materials and designs.
Carl Zeiss Meditec AG and Essilor Group contribute with their expertise in precision optics and eyeglass lenses, offering solutions that enhance visual clarity and comfort for astigmatism patients. Seed Co., Ltd. and Menicon Co., Ltd., with their innovative contact lens technologies, play crucial roles in the Asian market, reflecting the industry's global reach and adaptability to diverse consumer needs.
Astigmatism Industry Key Players
- Novartis AG
- SEA VISION S.r.l.
- Johnson & Johnson Services, Inc.
- Bauch and Lomb
- CooperVision
- Carl Zeiss Meditec AG
- Seed Co., Ltd.
- Essilor Group.
- Menicon Co., Ltd.
- Benq Materials Corporation
Astigmatism Market Recent Development
- Jan 2024 BVI is making a major step in its growth path through the acquisition of Medical Mix, a specialized medical device manufacturer that is focused on ophthalmic surgeries in Spain as well as Portugal.
- Dec 2023 HCP Cureblindness announced the acquisition of SightLife International, the global division of the SightLife company, marking a significant consolidation in the eye health sector of non-profit organizations.
- Dec 2023 Vantage Surgical Solutions has acquired Ophthalmic Surgical Solutions (OSS) an acclaimed company located in Kansas which is a specialist in ophthalmic surgical equipment as well as services. This acquisition demonstrates Vantage Surgical Solutions' commitment to expanding its product line and offering a range of surgical solutions that meet the changing demands of the ophthalmic surgical environment.
Report Scope
Report Features Description Market Value (2023) USD 2.69 Billion Forecast Revenue (2033) USD 5.8 Billion CAGR (2024-2032) 8.12% Base Year for Estimation 2023 Historic Period 2016-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Type(Myopic Astigmatism, Hyperopic Astigmatism, Mixed Astigmatism, Others), By Treatments(Corrective Lenses, Orthokeratology {Ortho-K}, Surgeries, Others), By End User(Hospitals, Clinics, Others) Regional Analysis North America - The US, Canada, Rest of North America, Europe - Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe, Asia-Pacific - China, Japan, South Korea, India, New Zealand, Singapore, Thailand, Vietnam, Rest of Asia Pacific, Latin America - Brazil, Mexico, Rest of Latin America, Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa Competitive Landscape Novartis AG, SEA VISION S.r.l., Johnson & Johnson Services, Inc., Bauch and Lomb, CooperVision, Carl Zeiss Meditec AG, Seed Co., Ltd., Essilor Group., Menicon Co., Ltd., Benq Materials Corporation Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
-